Frances Oldham Kelsey

From WikiMD.com - Food, Medicine & Wellness Encyclopedia

Frances Oldham Kelsey (July 24, 1914 – August 7, 2015) was a Canadian-American pharmacologist and physician. As a reviewer for the U.S. Food and Drug Administration (FDA), she refused to authorize Thalidomide for market because she had concerns about the drug's safety. Her concerns proved to be justified when it was shown that Thalidomide caused serious birth defects. Kelsey's work on the drug's testing process led to major reforms in the FDA's drug approval process.

Early life and education[edit | edit source]

Kelsey was born in Cobble Hill, British Columbia, on Vancouver Island, in 1914. She attended McGill University, where she received both her B.S. in 1934 and M.S. in 1935. She was awarded a Ph.D. from the University of Chicago in 1938.

Career[edit | edit source]

In 1960, Kelsey was hired by the FDA in Washington, D.C. She is best known for her work at the FDA, where she became a reviewer for new drug applications. In this role, she made a significant impact on the future of drug testing and approval processes.

Thalidomide[edit | edit source]

In 1960, Kelsey received an application from the William S. Merrell Company for the drug Thalidomide, which was already being sold in Europe as a sedative and morning sickness cure. Kelsey was not convinced of its safety and requested further studies. Her insistence on rigorous testing saved countless newborns in the U.S. from the devastating effects of the drug, which was later found to cause severe birth defects.

Legacy[edit | edit source]

Kelsey's work led to the passing of laws strengthening the FDA's oversight of pharmaceuticals. She was awarded the President's Award for Distinguished Federal Civilian Service by President John F. Kennedy, becoming the second woman to receive this award.

See also[edit | edit source]

References[edit | edit source]


WHO Rod.svg
This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia

Frances Oldham Kelsey[edit | edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Transform your life with W8MD's budget GLP1 injections from $125

W8mdlogo.png
W8MD weight loss doctors team

W8MD offers a medical weight loss program NYC and a clinic to lose weight in Philadelphia. Our W8MD's physician supervised medical weight loss centers in NYC provides expert medical guidance, and offers telemedicine options for convenience.

Why choose W8MD?

Book Your Appointment

Start your NYC weight loss journey today at our NYC medical weight loss, and Philadelphia medical weight loss Call (718)946-5500 for NY and 215 676 2334 for PA

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's NYC physician weight loss.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available. Call 718 946 5500.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD